Hong Chong Kim
Examiner (ID: 196, Phone: (571)272-4181 , Office: P/2138 )
Most Active Art Unit | 2138 |
Art Unit(s) | 2188, 2138, 2187, 2185, 2312, 2186, 2751 |
Total Applications | 1152 |
Issued Applications | 1001 |
Pending Applications | 21 |
Abandoned Applications | 130 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18932231
[patent_doc_number] => 11884637
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-30
[patent_title] => 3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound
[patent_app_type] => utility
[patent_app_number] => 18/238713
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3827
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18238713
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/238713 | 3-(4-chlorophenyl)-5-{[5-methyl-2-(propan-2-yl)phenoxy]methyl}-1,2,4-oxadiazole as an antitumor and antimicrobial compound | Aug 27, 2023 | Issued |
Array
(
[id] => 18690879
[patent_doc_number] => 20230321041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => BLEND CONTAINING CARBAMATE COMPOUND FOR PREVENTION, MITIGATION, OR TREATMENT OF SCHIZOPHRENIA
[patent_app_type] => utility
[patent_app_number] => 18/210215
[patent_app_country] => US
[patent_app_date] => 2023-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18210215
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/210215 | BLEND CONTAINING CARBAMATE COMPOUND FOR PREVENTION, MITIGATION, OR TREATMENT OF SCHIZOPHRENIA | Jun 14, 2023 | Pending |
Array
(
[id] => 18672953
[patent_doc_number] => 20230310407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => RADIATION MITIGATOR AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/207447
[patent_app_country] => US
[patent_app_date] => 2023-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12094
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18207447
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/207447 | RADIATION MITIGATOR AND METHOD OF USE THEREOF | Jun 7, 2023 | Pending |
Array
(
[id] => 18649346
[patent_doc_number] => 20230295140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => INHIBITORS OF VAP-1
[patent_app_type] => utility
[patent_app_number] => 18/201715
[patent_app_country] => US
[patent_app_date] => 2023-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18201715
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/201715 | INHIBITORS OF VAP-1 | May 23, 2023 | Pending |
Array
(
[id] => 18753862
[patent_doc_number] => 20230357170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => CFTR REGULATORS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/316183
[patent_app_country] => US
[patent_app_date] => 2023-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316183
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316183 | CFTR regulators and methods of use thereof | May 10, 2023 | Issued |
Array
(
[id] => 19291528
[patent_doc_number] => 12030874
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Processes and intermediates for the preparation of soluble guanylate cyclase stimulators
[patent_app_type] => utility
[patent_app_number] => 18/140966
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 46546
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140966
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140966 | Processes and intermediates for the preparation of soluble guanylate cyclase stimulators | Apr 27, 2023 | Issued |
Array
(
[id] => 18567017
[patent_doc_number] => 20230257346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 18/306652
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18306652
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/306652 | Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor | Apr 24, 2023 | Issued |
Array
(
[id] => 18871120
[patent_doc_number] => 11858905
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-01-02
[patent_title] => Cathepsin L inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/194609
[patent_app_country] => US
[patent_app_date] => 2023-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 61
[patent_no_of_words] => 24586
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18194609
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/194609 | Cathepsin L inhibitors | Mar 30, 2023 | Issued |
Array
(
[id] => 18522937
[patent_doc_number] => 20230233587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => REMDESIVIR TREATMENT METHODS
[patent_app_type] => utility
[patent_app_number] => 18/128850
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19046
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18128850
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/128850 | Remdesivir treatment methods | Mar 29, 2023 | Issued |
Array
(
[id] => 18674999
[patent_doc_number] => 20230312537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => NEPRILYSIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/173573
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173573
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173573 | Neprilysin inhibitors | Feb 22, 2023 | Issued |
Array
(
[id] => 18724243
[patent_doc_number] => 20230338373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO)
[patent_app_type] => utility
[patent_app_number] => 18/166789
[patent_app_country] => US
[patent_app_date] => 2023-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166789
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166789 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | Feb 8, 2023 | Issued |
Array
(
[id] => 19120998
[patent_doc_number] => 11964968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Compounds useful for inhibiting RET kinase
[patent_app_type] => utility
[patent_app_number] => 18/165037
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29912
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165037
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/165037 | Compounds useful for inhibiting RET kinase | Feb 5, 2023 | Issued |
Array
(
[id] => 18707529
[patent_doc_number] => 20230330105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
[patent_app_type] => utility
[patent_app_number] => 18/162398
[patent_app_country] => US
[patent_app_date] => 2023-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162398
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/162398 | METHODS AND COMPOSITIONS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT | Jan 30, 2023 | Abandoned |
Array
(
[id] => 18656101
[patent_doc_number] => 20230301975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/160060
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 450
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160060
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160060 | Deuterated compounds for restoring mutant p53 function | Jan 25, 2023 | Issued |
Array
(
[id] => 18980115
[patent_doc_number] => 11905275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Bipyrazole derivatives as JAK inhibitors
[patent_app_type] => utility
[patent_app_number] => 18/101014
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 29039
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 571
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101014
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/101014 | Bipyrazole derivatives as JAK inhibitors | Jan 23, 2023 | Issued |
Array
(
[id] => 18375874
[patent_doc_number] => 20230150955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => COMPOUND HAVING OXADIAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/155924
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155924
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155924 | COMPOUND HAVING OXADIAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | Jan 17, 2023 | Pending |
Array
(
[id] => 18389075
[patent_doc_number] => 20230157293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => NAPHTHALENE ISOXAZOLINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS
[patent_app_type] => utility
[patent_app_number] => 18/097814
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 270
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18097814
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/097814 | NAPHTHALENE ISOXAZOLINE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | Jan 16, 2023 | Pending |
Array
(
[id] => 18389785
[patent_doc_number] => 20230158003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => Sphingosine Pathway Modulating Compounds For The Treatment Of Coronavirus Infection
[patent_app_type] => utility
[patent_app_number] => 18/153319
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153319
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153319 | Sphingosine pathway modulating compounds for the treatment of coronavirus infection | Jan 10, 2023 | Issued |
Array
(
[id] => 18524265
[patent_doc_number] => 20230234922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PROCESSES FOR THE PREPARATION OF 4,6,7-TRIFLUORO-1H-INDOLE-2-CARBOXYLIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/095155
[patent_app_country] => US
[patent_app_date] => 2023-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17833
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18095155
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/095155 | Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid | Jan 9, 2023 | Issued |
Array
(
[id] => 18536140
[patent_doc_number] => 20230241227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 18/151904
[patent_app_country] => US
[patent_app_date] => 2023-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18151904
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/151904 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | Jan 8, 2023 |